<SEC-DOCUMENT>0001683168-16-000889.txt : 20161209
<SEC-HEADER>0001683168-16-000889.hdr.sgml : 20161209
<ACCEPTANCE-DATETIME>20161209080055
ACCESSION NUMBER:		0001683168-16-000889
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20161208
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20161209
DATE AS OF CHANGE:		20161209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIMULATIONS PLUS INC
		CENTRAL INDEX KEY:			0001023459
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		IRS NUMBER:				954595609
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32046
		FILM NUMBER:		162042824

	BUSINESS ADDRESS:	
		STREET 1:		42505 10TH STREET WEST
		STREET 2:		*
		CITY:			LANCASTER
		STATE:			CA
		ZIP:			93534-7059
		BUSINESS PHONE:		661-723-7723

	MAIL ADDRESS:	
		STREET 1:		42505 10TH STREET WEST
		CITY:			LANCASTER
		STATE:			CA
		ZIP:			93534-7059
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>simulations_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><B>UNITED STATES</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">FORM 8-K</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">December 8, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">(Date of the
earliest event reported)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Simulations Plus, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">(Exact name
of registrant as specified in its charter)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">California</FONT></TD>
    <TD STYLE="width: 33%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">001-32046</FONT></TD>
    <TD STYLE="width: 34%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">95-4595609</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(State or other jurisdiction</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">&nbsp;of incorporation)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(Commission</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">&nbsp;File Number)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(I.R.S. Employer</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">&nbsp;Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">42505 10<SUP>th</SUP> Street West, Lancaster,
California 93534-7059</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">(Address of
principal executive offices) (Zip Code)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">661-723-7723</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">Registrant's
telephone number, including area code</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left">&#9744;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-weight: normal">&#9744;</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Soliciting material pursuant to Rule 14z-12 under
Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left">&#9744;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Pre-commencement communications pursuant to Rule
14d-2(b) under Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left">&#9744;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Pre-commencement communications pursuant to Rule
13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><B>Item 8.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Other
Events</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 8, 2016, Simulations Plus, Inc.,
a California corporation (the &quot;Company&quot;), issued a press release announcing preliminary revenues for its first fiscal
quarter ended November 30, 2016. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The information contained in this Current Report
on Form 8-K shall not be deemed to be &quot;filed&quot; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the &quot;Exchange Act&quot;), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended (the &quot;Securities Act&quot;), or the Exchange Act,
except as shall be expressly set forth by specific reference in such a filing. The information set forth in this Current Report
on Form 8-K shall not be deemed an admission as to the materiality of any information in this report on Current Report on Form
8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CAUTION REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Current Report on Form 8-K may contain
forward-looking statements that are made pursuant to the safe harbor provisions of Section 21E of the Exchange Act. The forward-looking
statements in this Current Report on Form 8-K are not historical facts, do not constitute guarantees of future performance and
are based on numerous assumptions which, while believed to be reasonable, may not prove to be accurate. Any forward-looking statements
in this Current Report on Form 8-K do not constitute guarantees of future performance and involve a number of factors that could
cause actual results to differ materially, including risks more fully described in our most recently filed Quarterly Report on
Form 10-Q and Annual Report on Form 10-K. The Company assumes no obligation to update any forward-looking information contained
in this Current Report or with respect to the announcements described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial
Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-indent: -0.75in">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press
release issued on December 8, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIMULATIONS PLUS, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: December 9, 2016</FONT></TD>
    <TD STYLE="text-decoration: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: <U>/s/ John
    R. Kneisel</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;John R. Kneisel</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>simulations_8k-ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="logo.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For Further Information:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Simulations Plus, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">42505 10<SUP>th</SUP> Street West</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Lancaster, CA 93534-7059</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>CONTACT</B>:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-decoration: underline"><FONT STYLE="font-size: 10pt"><U>Simulations Plus Investor Relations</U></FONT></TD>
    <TD STYLE="width: 50%; text-decoration: underline"><FONT STYLE="font-size: 10pt"><U>Hayden IR</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Ms. Renee Bouche</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Mr. Cameron Donahue</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">661-723-7723</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">651-653-1854</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">renee@simulations-plus.com</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">cameron@haydenir.com</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For Immediate Release:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">December 8, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Simulations Plus Reports Record Preliminary
Revenues for First Quarter FY2017</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>LANCASTER, CA, </B>December 8, 2016 <B>&ndash;
</B>Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and
development, today released preliminary revenues for the first quarter of its fiscal year 2017, ending November 30, 2016 (1QFY17).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. John Kneisel, chief financial officer of
Simulations Plus, stated: &ldquo;In accordance with our policy to release timely financial information to our shareholders, we
are releasing preliminary revenues for 1QFY17. Earnings will not be released until just prior to the filing of our quarterly report
on Form 10-Q. We expect to file our 10-Q with the U.S. Securities and Exchange Commission on or before the January 9, 2017 deadline.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Preliminary results for the quarter:</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Preliminary revenues increased 10.9% or $525,000, to $5.36 million, compared to $4.84 million for
the same period in 2016.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify">Software and software-related services increased $217,000 or 6.8%, to $3.40 million or 63.4% of
revenues for 1QFY17 compared to 1QFY16</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>Consulting service revenues increased $308,000, or 18.6%, to $1.96 million or 36.6% of revenues for 1QFY17 compared to 1QFY16</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD>Preliminary revenues in our Buffalo division increased $246,000 or 17.2%, to $1.67 million for 1QFY17 compared to 1QFY16</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">During 1QFY17, the company added 23 new software customers.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Cash as of November 30, 2016, was $8.85 million after the Company made a dividend distribution
of approximately $861,000 on November 17, 2016.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">John DiBella, vice president for marketing
and sales of Simulations Plus, said: &ldquo;With more pharmaceutical companies requesting the services of our expert consultants
on a wide range of projects, plus consistent growth seen with in-house licensing of our technology, FY17 is off to a strong start.
We were very pleased to see the U.S. Environmental Protection Agency (EPA) and Centers for Disease Control and Prevention (CDC)
continue to add more licenses of our top-ranked ADMET Predictor&trade; and GastroPlus&trade; modeling software to assist with their
safety research and toxicology initiatives. With training workshops scheduled around the world in 2017, plus new software releases
expected over the next few months, we expect to educate more scientists and continue to expand our client base.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>About Simulations Plus, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Simulations Plus, Inc. is a premier developer
of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting
services for regulatory submissions. The company is a global leader focused on improving the ways scientists use knowledge and
data to predict the properties and outcomes of pharmaceutical and biotechnology agents. Our software is licensed to and used in
the conduct of drug research by major pharmaceutical and biotechnology companies and regulatory agencies worldwide. Our innovations
in integrating new and existing science in medicinal chemistry, computational chemistry, pharmaceutical science, biology, and physiology
into our software have made us the leading software provider for physiologically based pharmacokinetic modeling and simulation.
For more information, visit our website at www.simulations-plus.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Safe Harbor Statement Under the Private
Securities Litigation Reform Act of 1995</B> &ndash; With the exception of historical information, the matters discussed in this
press release are forward-looking statements that involve a number of risks and uncertainties. Words like &ldquo;believe,&rdquo;
&ldquo;expect&rdquo; and &ldquo;anticipate&rdquo; mean that these are our best estimates as of this writing, but that there can
be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ
significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to:
our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by
our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to
attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the Company,
and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports as filed with
the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Follow us on Twitter</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">###</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  S 0D# 2(  A$! Q$!_\0
M'    P$  P$!              8'!0$#! ((_\0 .Q   0,$  0$ P8$! <
M     0(#!  %!A$'$B$Q$R)!411A@14R<9&AL0@6(U(70F+!,V-R@I*BT?_$
M !D! 0 # 0$                ! @,$!?_$ "D1  $$ 0,#! (# 0
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24441%%%%$11111$44441?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
